实用肝脏病杂志 ›› 2022, Vol. 25 ›› Issue (5): 628-632.doi: 10.3969/j.issn.1672-5069.2022.05.006

• 实验性肝炎 • 上一篇    下一篇

新型促癌基因LSM11通过Wnt/β-catenin信号通路促进肝癌细胞增殖*

胡鹏蕴, 赵宏峰, 杨小伟, 史保宾   

  1. 453000 河南省新乡市中心医院肿瘤外科(胡鹏蕴,赵宏峰,杨小伟,史保宾);新乡医学院第四临床学院(胡鹏蕴,赵宏峰)
  • 收稿日期:2022-02-18 出版日期:2022-09-10 发布日期:2022-09-22
  • 通讯作者: 赵宏峰,E-mail: zhfengyn@163.com
  • 作者简介:胡鹏蕴,男,37岁,医学硕士,主治医师。主要从事消化系统肿瘤诊治研究。E-mail: hpy20152017@163.com
  • 基金资助:
    国家“十三五”科技重大专项中医药综合治疗延缓乙型肝炎相关肝癌进展研究(编号:2018ZX10303502-001/2018ZX10303502-002)

A novel oncogenic gene LSM11 promotes the proliferation of HCC cells by through the Wnt/β-catenin signaling pathway

Hu Pengyun, Zhao Hongfeng, Yang Xiaowei, et al.   

  1. Department of Oncology, Central Hospital, Xinxiang 453000, Henan Province, China
  • Received:2022-02-18 Online:2022-09-10 Published:2022-09-22

摘要: 目的 探讨乙型肝炎病毒(HBV)或丙型肝炎病毒(HCV)感染促进肝癌细胞增殖的潜在机制。方法 取肝癌细胞HepG2和Huh7细胞,转染HBV或HCV。采用转录组水平高通量测序和小干扰核糖核酸遗传学筛选,鉴定HBV或HCV感染后影响细胞增殖水平的关键基因。过表达或敲低上述基因后,采用高通量测序和通路富集分析基因功能。结果 在转染HBV后,肝癌细胞HepG2和Huh7增殖水平分别为(1.01±0.09)和(0.97±0.09),显著高于转染前【分别为(0.61±0.12)和(0.60±0.12),P<0.05];转染HCV后,肝癌细胞HepG2和Huh7增殖活性分别为(1.10±0.09)和(1.03±0.08),显著高于转染前【分别为(0.65±0.13)和(0.52±0.11),P<0.05】;敲低LSM11后,肝癌细胞HepG2和Huh7增殖活性分别为(0.39±0.06)和(0.34±0.04),显著低于未敲低前【分别为(0.49±0.02)和(0.50±0.06),P<0.05】;过表达LSM11,肝癌细胞HepG2和Huh7增殖活性分别为(1.04±0.07)和(1.02±0.08),显著高于未过表达【分别为(0.54±0.11)和(0.50±0.12),P<0.05】;敲低LSM11或过表达LSM11后,进行高通量测序并将受调控的基因进行通路富集分析,发现LSM11可以显著影响Wnt/β-catenin通路的产物表达;在敲低LSM11后,HepG2和Huh7细胞β-catenin活性分别为(1235±69)和(884±95),显著低于未敲低前【分别为(23645±256)和(19482±119),P<0.05】;在过表达LSM11后,HepG2和Huh7细胞β-catenin活性分别为(43999±2345)和(39572±3912),显著高于未过表达【分别为(25281±281)和(2004±145),P<0.05】;经免疫共沉淀检测发现LSM11与β-catenin存在相互作用。结论 肝癌细胞感染HBV或HCV后,LSM11表达水平升高,而LSM11与Wnt/β-catenin信号通路中关键转录因子β-catenin结合并增强了β-catenin的功能活性。

关键词: HepG2, Huh7细胞, LSM11, Wnt, β-catenin, 乙型肝炎病毒, 丙型肝炎病毒, 体外

Abstract: Objective The purpose of this study was to investigate the potential mechanism of hepatitis B virus (HBV) or hepatitis C virus (HCV) infection promoting the proliferation of hepatocellular carcinoma cells. Methods The proliferation of HepG2 and Huh7 cells after HBV or HCV infection was detected by MTT. The key genes that affected the proliferation of hepatoma cells after HBV or HCV infection were assayed by high-throughput transcriptome sequencing and small interfering ribonucleic acid genetic screening. After overexpression or knockdown of these genes, their functions were analyzed by high-throughput sequencing and pathway enrichment. Results After HBV transinfection, the proliferation of HepG2 and Huh7 cells were (1.01±0.09)and(0.97±0.09), significantly higher than [(0.61±0.12)and(0.60±0.12), respectively, P<0.05] before transinfection; the proliferation activities of HepG2 and Huh7 cells after HCV transinfection were (1.10±0.09)and(1.03±0.08), significantly higher than [(0.65±0.13)and(0.52±0.11), respectively, P<0.05] before transinfection; when the LSM11 was knocked down, the proliferation of HepG2 and Huh7 cells were (0.39±0.06)and(0.34±0.04), significantly lower than [(0.49±0.02)and (0.50±0.06), respectively, P<0.05] without knock-down; the proliferation of HepG2 and Huh7 cells when overexpression of LSM11 were (1.04±0.07)and(1.02±0.08), significantly higher than [(0.54±0.11)and(0.50±0.12), P<0.05] without overexpression; the high-throughput sequencing and pathway enrichment analysis of the regulated genes after LSM11 knockdown or overexpression showed that LSM11 could significantly affect the product expression of Wnt/β-catenin pathway; after LSM11 knockeddown, the β-catenin activity in HepG2 and Huh7 cells were(1235±69)and(884±95), significantly lower than [(23645±256)and(19482±119), P<0.05] without knocked-down; the activity of β-catenin after LSM11 overexpression in HepG2 and Huh7 cells were (43999±2345)and(39572±3912), significantly higher than [(25281±281)and(2004±145), P<0.05] without overexpression; in addition, the interaction between LSM11 and β-catenin was observed by immunoprecipitation. Conclusion After HBV or HCV transinfection, the expression of LSM11 in hepatocellular carcinoma cells is increased, and LSM11 could bind to β-catenin, a key transcription factor in Wnt/β-catenin signaling pathway, and enhance the functional activity of β-catenin.

Key words: HepG2, Huh7, LSM11, Wnt, β- catenin, HBV, HCV, In vitro